N-({1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]-1H-1,2,3-triazol-4-yl}methyl)-4-sulfamoylbenzamide

InChIKey	`ROBXYFBYHQCBMD-AUPCZCKCSA-N`
Compound Name	N-({1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]-1H-1,2,3-triazol-4-yl}methyl)-4-sulfamoylbenzamide
Canonical SMILES	`NS(=O)(=O)c1ccc(C(=O)NCc2cn([C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)nn2)cc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.21
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	8.5	Ki	ChEMBL;BindingDB
Q9ULX7	CA14	Homo sapiens	Human	PF00194	7.2	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	6.6	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	6.6	pIC50	TTD_MultiTarget